Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 367

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Medications safety pharmacoeconomics-related issues

Al-Worafi, Yaser Mohammed·2020·Drug Safety in Developing Countries

Abstract

Abstract The cost of drug-related problems (DRPs), medication errors, counterfeit and substandard medications, and medication abuse and misuse is high worldwide and affects the health expenditure. Pharmacoeconomics play an important role in the medication safety practice, it can be used to estimate the cost of adverse drug reactions, DRPs, medication errors, and the impact of medication safety practice in reducing the health expenditure. This chapter aims to discuss the medication safety pharmacoeconomic-related issues and budget requirements and types for establishing a strong medications safety system. Study of the direct and indirect cost of medications safety issues is very important and highly recommended. Study of the economic impact of medication safety systems and practices on reducing the health expenditure is very important and highly recommended. Study of the impact of medications safety interventions on reducing the health expenditure is very important and highly recommended.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/b978-0-12-819837-7.00016-9

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Metadata

Authors
Al-Worafi, Y. M.
Venue
Drug Safety in Developing Countries
Publisher
Elsevier
Published
2020
Pages
187-195
OpenAlex
W3034102747
Cited by
367
References
15
FWCI
98.66
Type
book chapter
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Medications safety pharmacoeconomics-related issues. https://app.cochat.ai/papers/10.1016/b978-0-12-819837-7.00016-9
The paper
Al-Worafi, Y. M. (2020). Medications safety pharmacoeconomics-related issues. Drug Safety in Developing Countries. https://doi.org/10.1016/b978-0-12-819837-7.00016-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.